123 related articles for article (PubMed ID: 38092007)
1. Platinum Prodrug Nanoparticles with COX-2 Inhibition Amplify Pyroptosis for Enhanced Chemotherapy and Immune Activation of Pancreatic Cancer.
Yu B; Wang Y; Bing T; Tang Y; Huang J; Xiao H; Liu C; Yu Y
Adv Mater; 2024 Mar; 36(11):e2310456. PubMed ID: 38092007
[TBL] [Abstract][Full Text] [Related]
2. [Antitumor effects of redox-responsive nanoparticles containing platinum（Ⅳ）in ovarian cancer].
Hou HY; Tang DS; Zhang YN; Wang KY; Ao M; Luo HX; Li B
Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):76-85. PubMed ID: 38246783
[No Abstract] [Full Text] [Related]
3. Targeting DNA Damage and Repair Machinery via Delivering WEE1 Inhibitor and Platinum (IV) Prodrugs to Stimulate STING Pathway for Maximizing Chemo-Immunotherapy in Bladder Cancer.
Wang W; Yang F; Zhang L; Wang M; Yin L; Dong X; Xiao H; Xing N
Adv Mater; 2024 Jan; 36(1):e2308762. PubMed ID: 37849029
[TBL] [Abstract][Full Text] [Related]
4. Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer.
Wang Y; Luo Z; Zhou D; Wang X; Chen J; Gong S; Yu Z
Biomater Sci; 2021 Jun; 9(11):4110-4119. PubMed ID: 33949442
[TBL] [Abstract][Full Text] [Related]
5. Corrosion-Activated Chemotherapeutic Function of Nanoparticulate Platinum as a Cisplatin Resistance-Overcoming Prodrug with Limited Autophagy Induction.
Cheng HJ; Wu TH; Chien CT; Tu HW; Cha TS; Lin SY
Small; 2016 Nov; 12(44):6124-6133. PubMed ID: 27717137
[TBL] [Abstract][Full Text] [Related]
6. GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer.
Huang H; Dong Y; Zhang Y; Ru D; Wu Z; Zhang J; Shen M; Duan Y; Sun Y
Theranostics; 2019; 9(4):1047-1065. PubMed ID: 30867815
[No Abstract] [Full Text] [Related]
7. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032
[TBL] [Abstract][Full Text] [Related]
8. Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance.
Ling X; Chen X; Riddell IA; Tao W; Wang J; Hollett G; Lippard SJ; Farokhzad OC; Shi J; Wu J
Nano Lett; 2018 Jul; 18(7):4618-4625. PubMed ID: 29902013
[TBL] [Abstract][Full Text] [Related]
9. Microenvironment-Responsive Prodrug-Induced Pyroptosis Boosts Cancer Immunotherapy.
Xiao Y; Zhang T; Ma X; Yang QC; Yang LL; Yang SC; Liang M; Xu Z; Sun ZJ
Adv Sci (Weinh); 2021 Dec; 8(24):e2101840. PubMed ID: 34705343
[TBL] [Abstract][Full Text] [Related]
10. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood.
Datta P; Bang S; Yue Z; Beach T; Stilgenbauer M; Wang H; Bowers DJ; Kurokawa M; Xiao H; Zheng YR
Dalton Trans; 2020 Jun; 49(24):8107-8113. PubMed ID: 32490446
[TBL] [Abstract][Full Text] [Related]
11. Fabricating nanoparticles co-loaded with survivin siRNA and Pt(IV) prodrug for the treatment of platinum-resistant lung cancer.
Ma S; Li X; Ran M; Ji M; Gou J; Yin T; He H; Wang Y; Zhang Y; Tang X
Int J Pharm; 2021 May; 601():120577. PubMed ID: 33839227
[TBL] [Abstract][Full Text] [Related]
12. Fighting against drug-resistant tumors by the inhibition of γ-glutamyl transferase with supramolecular platinum prodrug nano-assemblies.
Wang L; Liu Z; He S; He S; Wang Y
J Mater Chem B; 2021 Jun; 9(22):4587-4595. PubMed ID: 34059856
[TBL] [Abstract][Full Text] [Related]
13. A Trisulfide Bond Containing Biodegradable Polymer Delivering Pt(IV) Prodrugs to Deplete Glutathione and Donate H
Li X; Cai J; Zhang H; Sun S; Zhao S; Wang Z; Nie X; Xu C; Zhang Y; Xiao H
ACS Nano; 2024 Mar; 18(11):7852-7867. PubMed ID: 38437513
[TBL] [Abstract][Full Text] [Related]
14. Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy.
Yang GG; Pan ZY; Zhang DY; Cao Q; Ji LN; Mao ZW
ACS Appl Mater Interfaces; 2020 Sep; 12(39):43444-43455. PubMed ID: 32883070
[TBL] [Abstract][Full Text] [Related]
15. NIR-II Light Accelerated Prodrug Reduction of Pt(IV)-Incorporating Pseudo Semiconducting Polymers for Robust Degradation and Maximized Photothermal/Chemo-Immunotherapy.
Tang D; Zhou H; Cui M; Liang G; Zhang H; Xiao H
Adv Mater; 2023 Jul; 35(28):e2300048. PubMed ID: 37016274
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable and pH-Responsive Acetalated Dextran (Ac-Dex) Nanoparticles for NIR Imaging and Controlled Delivery of a Platinum-Based Prodrug into Cancer Cells.
Braga CB; Perli G; Becher TB; Ornelas C
Mol Pharm; 2019 May; 16(5):2083-2094. PubMed ID: 30901218
[TBL] [Abstract][Full Text] [Related]
17. RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy.
Hao Y; Chen Y; He X; Han R; Yang C; Liu T; Yang Y; Liu Q; Qian Z
Biomaterials; 2023 Feb; 293():121975. PubMed ID: 36580720
[TBL] [Abstract][Full Text] [Related]
18. Alantolactone-Loaded Pegylated Prodrug Nanocarriers for Synergistic Treatment of Cisplatin-Resistant Ovarian Cancer via Reactivating Mitochondrial Apoptotic Pathway.
Luo Z; Luo Y; Liang X; Lyu Q; Meng F; Chen X; Wang Y; Fang W; Li A; Zhou D
ACS Biomater Sci Eng; 2022 Jun; 8(6):2526-2536. PubMed ID: 35612599
[TBL] [Abstract][Full Text] [Related]
19. A cisplatin-based platinum(IV) prodrug containing a glutathione s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer.
Chen H; Wang X; Gou S
J Inorg Biochem; 2019 Apr; 193():133-142. PubMed ID: 30731264
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming axial ligands facilitates the self-assembly of a platinum(iv) prodrug: overcoming drug resistance and safer in vivo delivery of cisplatin.
Fang T; Ye Z; Wu J; Wang H
Chem Commun (Camb); 2018 Aug; 54(66):9167-9170. PubMed ID: 30062328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
